U

Valeo Pharma Inc. VPHIF

$0.00 $0.000.00% OTC PK
Recommendation
Dividend Power Score
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
--
52-Week Range
P/E (TTM)
EPS (TTM)
Access our Premium Ratings
Get Access

Rating

Reward
Risk

Rating Factors

Growth Index
Efficiency Index
Solvency Index
Total Return Index
Volatility Index
Dividend Yield Index

Company Overview

Valeo Pharma Inc. is a Canadian specialty pharmaceutical company focused on the commercialization of prescription products and select specialty healthcare brands in Canada. The company has operated primarily in the pharmaceuticals and healthcare distribution sectors, with an emphasis on respiratory, hospital specialty, neurology, and branded generics markets. Its business model historically centered on acquiring, licensing, and commercializing products from international pharmaceutical partners for the Canadian market rather than conducting large-scale in-house drug discovery.

The company’s principal revenue drivers have included sales from licensed and promoted pharmaceutical products across specialty therapeutic categories, supported by a national sales infrastructure targeting physicians, hospitals, and healthcare providers. Valeo built its positioning around access to Canadian commercialization expertise and an established specialty sales network. Public disclosures indicate the company expanded through licensing agreements and strategic partnerships with global pharmaceutical developers. Valeo Pharma was founded in Canada and evolved from a specialty commercialization platform into a broader branded pharmaceutical business serving the Canadian healthcare market.

Data compiled by narrative technology. May contain errors.
Sector

Income Statement

Total Revenue (TTM)
EBITDA (TTM)
EBIT (TTM)
Net Income (TTM)

Balance Sheet

Total Assets (Q)
Total Debt (Q)
Total Liabilities (Q)
Book Value Per Share (Q)

Cash Flow

Cash from Operations (TTM)
Cash from Investing (TTM)
Cash from Financing (TTM)
Net Change in Cash (TTM)

Filings

Filing Date
Thursday, September 12, 2024
Period Date
Sunday, June 30, 2024
Next Filing
(est)

Price History

Loading...
52-Week Range0% of range
Low
$0.00
Current
$0.00
High
$0.00
Beta
7-Day Total Return
--
30-Day Total Return
--
60-Day Total Return
--
90-Day Total Return
--
Year to Date Total Return
1-Year Total Return
2-Year Total Return
3-Year Total Return
5-Year Total Return
52-week Low
52-week High

Valuation

Market Cap
Enterprise Value
--
Price/Sales (TTM)
Price/Book (Q)

Dividends and Shares

Shares Outstanding
Dividend Per Share (Most Recent)
--
Dividend Per Share (TTM)
--

Corporate Info

Phone Number
(514) 694-0150
Address
16667 Hymus Boulevard
Kirkland, QC H9H 4R9
Country
Year Founded

Headlines

There are no news to display.